Zhaoyong Zhang
Overview
Explore the profile of Zhaoyong Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang Y, Wang Y, Wu S, Xu N, Zhang Z, Ruan Z, et al.
Ren Fail
. 2024 Jul;
46(2):2375103.
PMID: 38973376
Introduction: Cardiovascular events resulting from volume overload are a primary cause of mortality in hemodialysis patients. Bioelectrical impedance analysis (BIA) is significantly valuable for assessing the volume status of hemodialysis...
12.
He L, Wu Q, Zhang Z, Chen L, Yu K, Li L, et al.
Mol Pharm
. 2024 Jun;
21(8):3866-3879.
PMID: 38920116
The continuous evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evaded the efficacy of previously developed antibodies and vaccines, thus remaining a significant global public health threat. Therefore,...
13.
Wang Y, Hao A, Ji P, Ma Y, Zhang Z, Chen J, et al.
Nat Commun
. 2024 Jun;
15(1):5127.
PMID: 38879565
The Omicron subvariants BQ.1.1, XBB.1.5, and XBB.1.16 of SARS-CoV-2 are known for their adeptness at evading immune responses. Here, we isolate a neutralizing antibody, 7F3, with the capacity to neutralize...
14.
Liu B, Niu X, Deng Y, Zhang Z, Wang Y, Gao X, et al.
Cell Rep
. 2024 May;
43(6):114265.
PMID: 38805396
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein continues to evolve antigenically, impacting antibody immunity. D1F6, an affinity-matured non-stereotypic VH1-2 antibody isolated from a patient infected with...
15.
Li Y, Tang Y, Wang X, Zhu A, Liu D, He Y, et al.
Virol Sin
. 2024 Apr;
39(3):414-421.
PMID: 38677713
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, encodes several accessory proteins that have been shown to play crucial roles in regulating the innate immune response....
16.
Wang Y, Yan A, Song D, Duan M, Dong C, Chen J, et al.
Nat Commun
. 2024 Jan;
15(1):842.
PMID: 38287016
The constant emergence of SARS-CoV-2 variants continues to impair the efficacy of existing neutralizing antibodies, especially XBB.1.5 and EG.5, which showed exceptional immune evasion properties. Here, we identify a highly...
17.
Li K, Yan J, Zhang H, Lu C, Wang W, Guo M, et al.
Medicine (Baltimore)
. 2024 Jan;
103(3):e37031.
PMID: 38241544
The prognostic value of preoperative white blood cell to hemoglobin ratio (WHR) and fibrinogen to albumin ratio (FAR) in colorectal cancer (CRC) is unknown. The purpose of this study was...
18.
Wang Y, Zhang Z, Yang M, Xiong X, Yan Q, Cao L, et al.
Cell Rep
. 2024 Jan;
43(1):113653.
PMID: 38175758
Omicron, as the emerging variant with enhanced vaccine tolerance, has sharply disrupted most therapeutic antibodies. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the subgenus Sarbecovirus, members of which...
19.
Zhang Y, Sun J, Zheng J, Li S, Rao H, Dai J, et al.
Adv Sci (Weinh)
. 2023 Dec;
11(9):e2303366.
PMID: 38105421
To combat SARS-CoV-2 variants and MERS-CoV, as well as the potential re-emergence of SARS-CoV and spillovers of sarbecoviruses, which pose a significant threat to global public health, vaccines that can...
20.
Wang D, Xiang Q, Hu X, Zhang Y, Wu L, Zhang Z, et al.
Virology
. 2023 Nov;
589:109925.
PMID: 37984151
SARS-CoV-2 and its variants continue to threaten public health. Nanobodies that block the attachment of the RBD to host cell angiotensin-converting enzyme 2 (ACE2) represent promising drug candidates. In this...